Skip to search formSkip to main contentSkip to account menu

5,9-epoxy-16-phenoxy-prostaglandin F1

Known as: 5,9-E-16-P-PGF1, 5,9-epoxy-16-phenoxy-PGF1, Cyclopenta(b)pyran-2-butanoic acid, octahydro-6-hydroxy-5-(3-hydroxy-4-phenoxy-1-butenyl)-, (2R-(2alpha,4abeta,5beta(1E,3R*),6alpha,7abeta))- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Changes in endogenous prostacyclin in the rat brain during clinical death and after resuscitation.
By means of the radioimmunologic method changes of concentration of 6-keto-prostaglandin F1 alpha (PGF1 alpha)--the stable… 
1986
1986
Routine measurement of thromboxane B2 and the prostacyclin metabolite 6-keto-prostaglandin F1 alpha in plasma.
Thromboxane A2 (TXA2) is mainly formed in thrombocytes. It promotes thrombocyte aggregation and contracts the blood vessels. TXA2… 
1986
1986
[Thromboxane analyses in patients with chronic inflammatory bowel diseases].
Prostanoids are important for the pathogenesis of chronic inflammatory bowel diseases as mediators of inflammatory, immune and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)